Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Neoplasms 29Myelodysplastic Syndromes 24Multiple Myeloma 22Lymphoma, Non-Hodgkin 20Anemia 20Hodgkin Disease 19Anemia, Refractory, with Excess of Blasts 19Leukemia 18Anemia, Aplastic 18Leukemia, Lymphocytic, Chronic, B-Cell 17Hematologic Neoplasms 17Febrile Neutropenia 17Venous Thromboembolism 16Anemia, Sickle Cell 16Lymphoma, Follicular 15Myeloproliferative Disorders 14Lymphoma, Mantle-Cell 14Primary Myelofibrosis 13Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Thrombocytopenia 11Lymphoma, Large B-Cell, Diffuse 11Burkitt Lymphoma 11Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Chronic-Phase 10Congenital Abnormalities 10Neoplasms, Plasma Cell 9Lymphoma, Large-Cell, Immunoblastic 9

Interventions

Transplantation 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphopenia × Classical hematology × Clear all
NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Thomas Jefferson University

Phase NA Withdrawn
Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡